• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives 2-halopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines 2-halopyridines

Professional Introduction to Compound with CAS No. 1060812-06-7 and Product Name: 2-(6-chloropyridin-3-yl)-2-methylpropan-1-amine

The compound in question, identified by the CAS No. 1060812-06-7, is a meticulously synthesized molecule with the product name 2-(6-chloropyridin-3-yl)-2-methylpropan-1-amine. This compound belongs to the class of pyridine derivatives, which have garnered significant attention in the field of pharmaceutical and chemical research due to their diverse biological activities and structural versatility. The presence of a chloropyridine moiety and an amine functional group makes this molecule a promising candidate for further exploration in drug discovery and material science.

In recent years, pyridine-based compounds have been extensively studied for their potential applications in medicinal chemistry. The structural motif of 6-chloropyridine is particularly noteworthy, as it serves as a key pharmacophore in numerous bioactive molecules. This moiety is known to interact favorably with biological targets, thereby modulating various physiological processes. The introduction of a methylpropan-1-amine side chain enhances the compound's solubility and metabolic stability, making it an attractive scaffold for further derivatization.

One of the most compelling aspects of this compound is its potential role in the development of novel therapeutic agents. The chloropyridine core has been implicated in several pharmacological pathways, including inhibition of enzymes and receptors involved in inflammation, pain, and neurodegeneration. Recent studies have demonstrated that derivatives of 6-chloropyridine exhibit significant activity against a range of disease models, both in vitro and in vivo. For instance, research has shown that certain chloropyridine compounds can modulate the activity of Janus kinases (JAKs), which are central players in signal transduction pathways associated with autoimmune diseases.

The amine functional group in the molecular structure of 2-(6-chloropyridin-3-yl)-2-methylpropan-1-amine further contributes to its pharmacological potential. Amines are well-known for their ability to form hydrogen bonds with biological targets, thereby enhancing binding affinity and selectivity. This property makes them invaluable in the design of small-molecule drugs that require precise interaction with specific proteins or nucleic acids. Moreover, the amine group can be further functionalized through various chemical reactions, allowing for the creation of a diverse library of derivatives with tailored biological properties.

From a synthetic chemistry perspective, the preparation of 2-(6-chloropyridin-3-yl)-2-methylpropan-1-amine exemplifies the sophistication achieved in modern organic synthesis. The synthesis involves multi-step reactions that showcase the interplay between functional group transformations and structural elucidation techniques. Advanced methodologies such as cross-coupling reactions, nucleophilic substitutions, and catalytic hydrogenations are employed to construct the desired molecular framework accurately. These synthetic strategies not only highlight the compound's complexity but also underscore the advancements in synthetic organic chemistry that enable such precise constructions.

The chemical properties of this compound also make it a valuable tool for mechanistic studies in drug discovery. By understanding how different parts of the molecule interact with biological systems, researchers can gain insights into the underlying mechanisms of action for potential drugs. This knowledge is crucial for optimizing drug candidates to improve efficacy while minimizing side effects. Additionally, computational modeling techniques can be employed to predict how modifications to the structure might affect biological activity, providing a rational basis for designing more effective molecules.

In conclusion, 2-(6-chloropyridin-3-yl)-2-methylpropan-1-amine (CAS No. 1060812-06-7) represents a significant advancement in pharmaceutical chemistry. Its unique structural features—particularly the combination of a chloropyridine core and an amine side chain—position it as a versatile scaffold for drug development. Ongoing research continues to uncover new applications for this compound and its derivatives, reinforcing its importance as a building block for innovative therapies. As scientific understanding progresses, it is likely that compounds like this will play an increasingly pivotal role in addressing complex diseases and improving patient outcomes.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)